Registration Strip Icon for alerts Regístrate para obtener alertas en tiempo real, cartera personalizada y movimientos del mercado.

KALY

Kali (CE) (KALY)

Kali Inc (CE)
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:USOTC:KALY
FechaHoraFuenteTítuloSímboloCompañía
06/05/202112:17InvestorsHub NewsWirePAOG 2021 CBD Nutraceuticals Sales Plan Preview This Friday To Include ALKM and USMJ Partnership HighlightsUSOTC:KALYKali Inc (CE)
05/05/202112:30InvestorsHub NewsWirePAOG 2021 CBD Nutraceuticals Rollout Preview This Friday To Include ALKM and USMJ Partnership UpdatesUSOTC:KALYKali Inc (CE)
03/05/202114:22InvestorsHub NewsWirePAOG 2021 CBD Nutraceutical Sales Rollout Plan Presentation Scheduled This FridayUSOTC:KALYKali Inc (CE)
13/04/202108:35InvestorsHub NewsWirePAOG Announces Negotiations To Acquire Partnership Interest In Patented Cannabis Extraction TechnologyUSOTC:KALYKali Inc (CE)
12/04/202107:43InvestorsHub NewsWirePAOG Signals BUY - CBD Pharma Development Backed US PatentUSOTC:KALYKali Inc (CE)
08/04/202107:57InvestorsHub NewsWirePAOG U.S. Patent Backed CBD Pharmaceutical Development Remains On TrackUSOTC:KALYKali Inc (CE)
16/03/202108:17InvestorsHub NewsWirePAOG Targets September 2021 To Introduce CBD Nutraceuticals To Market Co-Packed By ALKM and Marketed Through USMJUSOTC:KALYKali Inc (CE)
10/03/202112:42InvestorsHub NewsWirePAOG Announces Save The Date For CBD Nutraceuticals Expansion UpdateUSOTC:KALYKali Inc (CE)
08/03/202110:32InvestorsHub NewsWirePAOG Announces RELAX-RX Nutraceutical For $18 Billion Anxiety And Depression Treatment MarketUSOTC:KALYKali Inc (CE)
03/02/202107:37InvestorsHub Cannabis NewsWirePAOG Announces $50,000 Estimated Q4 2020 Revenue From Cannabis Cultivation SubsidiaryUSOTC:KALYKali Inc (CE)
27/01/202108:18InvestorsHub Cannabis NewsWirePAOG Takes Next Step To Produce Cannabis NutraceuticalsUSOTC:KALYKali Inc (CE)
20/01/202108:52InvestorsHub Cannabis NewsWirePURA In Partnership With PAOG and ALKM Prepare For Biden Bull Cannabis MarketUSOTC:KALYKali Inc (CE)
13/01/202110:22InvestorsHub NewsWirePAOG Dividend Update Included In 2021 Cannabis Biopharmaceutical Strategic Update TomorrowUSOTC:KALYKali Inc (CE)
11/01/202110:10InvestorsHub NewsWirePAOG Cannabis Pharmaceutical and Nutraceutical 2021 Strategy Update Targeting $50 Billion Market Scheduled Thursday Jan 14, 2...USOTC:KALYKali Inc (CE)
22/12/202010:57InvestorsHub NewsWirePAOG Expects To Report First Post Acquisition Revenue In Q4 2020USOTC:KALYKali Inc (CE)
18/12/202008:10InvestorsHub NewsWirePAOG Targets First Revenue From $12.7 Billion Market Selling CBD COPD Nutraceutical Care Product LineUSOTC:KALYKali Inc (CE)
17/12/202011:34InvestorsHub Cannabis NewsWirePAOG Announces Puerto Rico Consortium For Clinical Investigation Engagement To Advance CBD COPD Nutraceutical Care SolutionUSOTC:KALYKali Inc (CE)
17/11/202008:41InvestorsHub NewsWirePAOG Publishes Q3 RPT Including PURA And KALY Acquisitions - Now One Key Step Closer To Dividend DistributionUSOTC:KALYKali Inc (CE)
23/10/202009:24InvestorsHub NewsWirePAOG Signs Clinical Research Organization (CRO) to Advance Respiratory Cannabis Treatment Through Regulatory ApprovalUSOTC:KALYKali Inc (CE)
21/10/202008:59InvestorsHub NewsWirePAOG Cannabis Drug Company Trends Bullish - $0.01 Breakout On Horizon?USOTC:KALYKali Inc (CE)
16/10/202012:46InvestorsHub NewsWirePAOG and PURA Announce Free Hemp Seed Giveaway To Promote CBD and Hemp AwarenessUSOTC:KALYKali Inc (CE)
15/10/202008:44InvestorsHub NewsWirePAOG Releases Cannabis Drug Development UpdateUSOTC:KALYKali Inc (CE)
05/10/202010:24InvestorsHub Cannabis NewsWirePAOG Taps Canopy Growth And Altria ResourceUSOTC:KALYKali Inc (CE)
30/09/202009:20InvestorsHub NewsWirePAOG Cannabis Pharmaceutical Research Initiative Gains New TractionUSOTC:KALYKali Inc (CE)
25/09/202008:03InvestorsHub NewsWireCOPD News Today: ALYI - Agreement Reached for Hemp Facility to Support Potential COPD Therapy RespRxUSOTC:KALYKali Inc (CE)
24/09/202012:00InvestorsHub NewsWirePAOG Expands Cannabis Pharma Treatment ResearchUSOTC:KALYKali Inc (CE)
08/09/202008:14InvestorsHub NewsWirePAOG Announces Analyst Report Update With $0.015 PPS 12-Month Target For New Cannabis Pharma BusinessUSOTC:KALYKali Inc (CE)
02/09/202009:17InvestorsHub NewsWirePAOG Announces OTC Markets Current Information Reporting StandardUSOTC:KALYKali Inc (CE)
13/08/202008:13InvestorsHub NewsWirePAOG - Under the Radar CBD Biopharma Player Could Offer Major UpsideUSOTC:KALYKali Inc (CE)
30/07/202014:25InvestorsHub Cannabis NewsWirePAOG Announces Acquisition Of RespRx Entering $200B Biopharma MarketUSOTC:KALYKali Inc (CE)
 Showing the most relevant articles for your search:USOTC:KALY